Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  IRRAS AB (publ)    IRRAS   SE0008321202

IRRAS AB (PUBL)

(IRRAS)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Stockholm
01/19/2021 01/20/2021 01/21/2021 01/22/2021 01/25/2021 Date
7.85(c) 7.72(c) 7.76(c) 7.4(c) 7.45 Last
65 316 78 851 138 947 222 763 39 592 Volume
-1.01% -1.66% +0.52% -4.64% +0.68% Change
More quotes
Financials
Sales 2020 8,39 M 1,01 M 1,01 M
Net income 2020 -131 M -15,8 M -15,8 M
Net cash position 2020 153 M 18,5 M 18,5 M
P/E ratio 2020 -3,12x
Yield 2020 -
Sales 2021 38,4 M 4,63 M 4,63 M
Net income 2021 -129 M -15,6 M -15,6 M
Net cash position 2021 31,0 M 3,75 M 3,75 M
P/E ratio 2021 -3,81x
Yield 2021 -
Capitalization 490 M 59,2 M 59,2 M
EV / Sales 2020 40,3x
EV / Sales 2021 12,0x
Nbr of Employees 42
Free-Float 56,4%
More Financials
Company
Irras AB is a Sweden-based medical technology company. It offers devices for fluid control and management for a broad range of brain pathologies, central nervous system (CNS) therapeutic applications and procedures. The offer comprises instruments and catheters for the clinical, monitoring and surgical applications for brain pathology indications called IRRAflow. The IRRAflow CNS System combines an External Drainage... 
More about the company
Notations Surperformance© of IRRAS AB (publ)
Trading Rating : Investor Rating :
More Ratings
All news about IRRAS AB (PUBL)
01/12IRRAS : Announces Collaboration with Karolinska University Hospital
AQ
2020IRRAS : Announces Expansion of IRRAflow Launch to Southeastern Europe
AQ
2020IRRAS : Announces Expansion of IRRAflow Launch to Latin America
AQ
2020IRRAS : Announces Expansion of IRRAflow Launch to The Netherlands
AQ
2020IRRAS : Awarded Breakthrough Technology Purchasing Agreement with Premier for Hu..
AQ
2020IRRAS : publishes Interim Report for the period January to September 2020
AQ
2020IRRAS : Q3 Report 2020 - invitation to conference call and audiocast
AQ
2020IRRAS : Announces Key IRRAflow Commercial Milestones in Germany
AQ
2020IRRAS : Announces Release of Clinical Data that Validates Safety and Effectivene..
AQ
2020IRRAS : Enhances Global Sales Organization, Adds Key Talent to Drive Adoption of..
AQ
2020IRRAS : publishes Interim Report for the period January to June 2020
AQ
2020IRRAS : Granted Sixth Patent for Hummingbird ICP Monitoring Product Line from Un..
AQ
2020IRRAS : Q2 Report 2020 - invitation to conference call and audiocast
AQ
2020IRRAS : Anders P. Wiklund, Chairman of the Board of Directors of IRRAS AB, has p..
AQ
2020IRRAS PUBL : Announces First Global Patient Treatment with Newly Developed Hummi..
AQ
More news
News in other languages on IRRAS AB (PUBL)

- No features available -

More news
Chart IRRAS AB (PUBL)
Duration : Period :
IRRAS AB (publ) Technical Analysis Chart | IRRAS | SE0008321202 | MarketScreener
Technical analysis trends IRRAS AB (PUBL)
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 11,50 SEK
Last Close Price 7,40 SEK
Spread / Highest target 62,2%
Spread / Average Target 55,4%
Spread / Lowest Target 48,6%
EPS Revisions
Managers and Directors
NameTitle
Kleanthis G. Xanthopoulos Chief Executive Officer & Director
Will Martin President & Chief Commercial Officer
Marios Fotiadis Chairman
Sabina Berlin Chief Financial Officer
Inger Gunnel Anita Tollstadius Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
IRRAS AB (PUBL)-11.38%59
STRYKER CORPORATION-2.09%90 163
SMITH & NEPHEW PLC9.50%19 774
INSPIRE MEDICAL SYSTEMS, INC.17.40%5 948
VENUS MEDTECH (HANGZHOU) INC.14.67%4 946
GLAUKOS CORPORATION15.83%3 917